The BALANCE Model: What CMSs GLP-1 Model Means for Eli Lilly and the Future of Obesity Treatment Decoding a pharmaceutical payment model that could reshape access to obesity treatmentor crumble under its own complexity At 4pm on December 23rd, while most of us were winding down for the holidays, CMS announced the BALANCE Model: their request for applications from GLP-1 manufacturers willing to negotiate directly with the federal government for expanded Medicare and Medicaid coverage
Clearly with 70 years experience and mandated HCP support patients still slip through the net into malnutrition
It is always wise to consult with your healthcare provider before starting any new routine, especially if you are pregnant, nursing, or taking medication.
Ang, L., Jaiswal, M., Martin, C
Uchikawa, E., Chen, Z., Xiao, G